Nucleic acid therapies: Cross-species optimization of viral vector-based gene editing in the heart
| Institution | Europäisches Laboratorium für Molekularbiologie (EMBL) |
|---|---|
| Project leader | Lars Steinmetz |
| Site | Heidelberg/Mannheim |
| Project type | Innovation Cluster |
| Funding | € 223.357,68 |
| Begin | 01.01.2024 |
| End | 31.12.2026 |
| Partnerprojekte |
Förderkennzeichen
81X2500403
Projektnummer
1834